PET scans augmented by injections of the beta-amyloid targeting tracer florbetaben F18 are effective at helping confirm or rule out Alzheimer’s disease in patients under evaluation for cognitive impairment.

A new MRI technique being studied at Memorial Sloan Kettering Cancer Center in New York City could cut the time needed to reveal whether a tumor is responding to treatment from a matter of weeks to just a few days.

Has overuse of mammography created an epidemic of breast cancer pseudo-survivorship? That was the provocative question asked in a recent editorial published by Forbes.

NorthStar Medical Radioisotopes and Westinghouse Electric have completed a memorandum of understanding under which the companies will explore the potential for producing medical radioisotopes in commercial nuclear reactors.  

A $2.5 million grant from the National Institutes of Health/National Cancer Institute will be given to the University of Oklahoma (OU) and Mercy Hospital Oklahoma City to go toward the development of new short-term breast cancer risk prediction models.

Who doesn’t like getting things for free? It’s even better when the freebies are used to incentivize patients to quit smoking or eat healthy. But should those gift cards, event tickets and t-shirts be used to get women to come in for a mammogram?

Researchers at the University of Maryland are conducting a clinical trial using MRI-guided focused ultrasound to target the globus pallidus, a structure within the brain that is related to Parkinson’s disease.

The FDA has cleared Eizo’s 5-megapixel monochrome monitor for breast tomosynthesis, the Japanese company has announced.